Cocrystal Pharma, Inc.

NasdaqCM:COCP Stock Report

Market Cap: US$13.7m

Cocrystal Pharma Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

NasdaqCM:COCP Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
31 Dec 25BuyUS$47,275Phillip FrostIndividual50,000US$0.95
30 Dec 25BuyUS$19,310Phillip FrostIndividual20,000US$0.97
26 Dec 25BuyUS$63,202Phillip FrostIndividual65,000US$0.97
26 Nov 25BuyUS$3,975Phillip FrostIndividual4,000US$1.00
25 Nov 25BuyUS$18,812Phillip FrostIndividual20,000US$0.94

Insider Trading Volume

Insider Buying: COCP insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of COCP?
Owner TypeNumber of SharesOwnership Percentage
Institutions665,0344.82%
Individual Insiders4,542,46533%
General Public8,576,56662.2%

Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 35.5%.

Top Shareholders

Top 25 shareholders own 37.77% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
13.1%
Phillip Frost
1,803,795US$1.8m35.1%no data
10%
Fred Hassan
1,383,009US$1.4m36.2%no data
4.62%
Raymond Schinazi
637,063US$632.5k0%no data
4.1%
Sue Wilcox
564,952US$560.9k0%no data
1.94%
The Vanguard Group, Inc.
268,080US$266.1k0%no data
0.93%
Renaissance Technologies LLC
127,928US$127.0k2.32%no data
0.54%
Geode Capital Management, LLC
73,929US$73.4k1.13%no data
0.54%
BlackRock, Inc.
73,746US$73.2k0%no data
0.32%
James Martin
44,167US$43.8k7,660%no data
0.29%
Roger Kornberg
39,769US$39.5k0%no data
0.26%
Sam Lee
36,355US$36.1k0%no data
0.23%
Neuberger Berman Investment Advisers LLC
31,886US$31.7k0%no data
0.23%
Richard Pfenniger
31,400US$31.2k842%no data
0.15%
Jane Street Group, LLC
21,044US$20.9k0%no data
0.15%
State Street Global Advisors, Inc.
20,543US$20.4k0%no data
0.091%
Parallel Advisors, LLC
12,611US$12.5k-17.2%no data
0.086%
Northern Trust Global Investments
11,921US$11.8k0%no data
0.066%
Bank of America Corporation
9,092US$9.0k-0.1%no data
0.043%
Morgan Stanley
5,863US$5.8k0%no data
0.024%
Tower Research Capital Europe Limited
3,298US$3.3k-9.96%no data
0.014%
Steven Rubin
1,955US$1.9k0%no data
0.013%
Wells Fargo & Company
1,812US$1.8k0%no data
0.0076%
Citigroup Inc.
1,053US$1.0k0%no data
0.0059%
Northwestern Mutual Wealth Management Company
817US$811.50%no data
0.0041%
UBS Asset Management AG
571US$566.6-97.4%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/01/04 11:10
End of Day Share Price 2026/01/02 00:00
Earnings2025/09/30
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Cocrystal Pharma, Inc. is covered by 4 analysts. 3 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Raghuram SelvarajuH.C. Wainwright & Co.
Robert LeBoyerNOBLE Capital Markets, Inc.
David BautzZacks Small-Cap Research